MENU
NGNE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Neurogene (NGNE) Earnings Date & Reports
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via Construct Tuning)... Show more
A.I. Advisor
published Earnings
NGNE is expected to report earnings to rise 25.71% to -132 cents per share on March 30
Q4'26
Est.
$-1.32
Q3'26
Beat
by $0.44
Q2'26
Beat
by $0.38
Q1'26
Missed
by $0.12
Q4'25
Beat
by $0.13
The last earnings report on November 09 showed earnings per share of -104 cents, beating the estimate of -149 cents. With 86.65K shares outstanding, the current market capitalization sits at 506.49M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Related Blogs
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
535 W 24th Street
Phone
+1 855 508-3568
Employees
131
Web
https://www.neurogene.com